What are Mission Vision & Core Values of Revvity Company?

Revvity Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What drives Revvity’s strategy and purpose?

Clear mission and vision statements align stakeholders and speed execution in life sciences. For Revvity—spun from PerkinElmer in 2023—these guide investment, R&D, and partnerships across genomics, diagnostics, and imaging.

Revvity serves pharma, diagnostics labs, academia, and government with reagents, instruments, software, and services, prioritizing clinically actionable science like NGS prep, newborn screening, and cell therapy analytics.

What are Mission Vision & Core Values of Revvity Company? Explore how purpose steers R&D, M&A, quality, and go-to-market focus; see Revvity Porter's Five Forces Analysis for strategic context.

Revvity’s mission focuses on enabling biopharma, clinical labs, public health programs and researchers in 190+ countries with reagents, instruments, informatics and services to speed discovery‑to‑clinic workflows and improve patient outcomes.

Target customers

Serves biopharma R&D, diagnostics labs, public health programs and academic/government researchers across 190+ countries.

Core offerings

Provides high‑value reagents (NGS, immunoassays), instruments (imaging, automation), informatics and lab services including screening and technical support.

Market scope

End‑to‑end solutions from discovery through development to clinical use, emphasizing translational workflows and regulatory readiness (IVD, CE‑IVDR).

Unique value

Breadth of workflow integration from chemistry to cloud, deep quality/regulatory expertise and a broad installed base that drives scale.

Mission in action

Supports screening of over 35 million newborns annually and NGS workflows that cut lab turnaround times by 20–40%, demonstrating impact on health outcomes.

Customer orientation

Predominantly customer‑centric and outcomes‑driven, using innovation to accelerate life‑transforming science and measurable clinical impact.

Revvity’s mission aligns product, regulatory and service strength to improve health outcomes, illustrated by newborn screening reach and measurable genomic workflow efficiencies. Read more in Competitors Landscape of Revvity

Revvity SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Revvity vision focuses on shortening bench-to-bedside cycles by linking wet‑lab chemistry with analytics and AI, scaling from centralized labs to point‑of‑care, and leading in genomics, newborn screening, and cell & gene therapy diagnostics.

Future orientation

Industry disruption: integrate wet‑lab chemistry with advanced analytics to boost diagnostic sensitivity and speed.

Global impact

Scale across centralized reference labs to decentralized point‑of‑care and public health surveillance.

Leadership ambition

Aim to be the trusted partner in genomics prep, prenatal/newborn screening, cell & gene testing, and digital lab ecosystems.

Revenue credibility

Recurring revenue exceeds 70% from reagents and consumables, supporting sustainable growth and valuation stability.

Regulatory strength

Deep regulatory and compliance capabilities help navigate IVDR, FDA modernization, and global market entry.

Informatics & AI

Aspirational scaling of informatics and AI decision‑support underpins long‑term clinical footprint expansion.

Official vision: 'To be the most trusted partner enabling scientists and clinicians to turn data into decisions that transform human health.' The vision is realistic given recurring revenue > 70% and robust regulatory expertise, while aspirational growth relies on scaling informatics and AI.

Owners & Shareholders of Revvity

Revvity PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Revvity core values center on delivering reliable, patient-focused diagnostics and life‑science tools while driving purposeful innovation and inclusive collaboration across teams and partners. These principles guide product quality, customer-centric roadmaps, and sustainable practices that support long-term healthcare impact.

Integrity & Quality

Decisions prioritize patient safety and data reliability through rigorous design controls, lot-to-lot QC, and transparent post-market actions to support audits and regulatory compliance.

Customer Obsession

Roadmaps target workflow pain points with solutions that improve throughput and uptime; field teams co-develop SOPs and service targets to maintain instrument availability above 95%.

Innovation with Purpose

R&D focuses on high-sensitivity assays, low-input genomics, and automation that cut sample-to-answer time by double digits; partnerships and hackathons accelerate translation to commercial kits.

Collaboration & Inclusion

Cross-functional squads and DEI initiatives broaden scientific talent and speed product readiness; partner ecosystems (OEMs, CROs, software vendors) enable interoperable solutions.

Read next: how mission and vision influence the company's strategic decisions, including portfolio prioritization and ESG targets—see Growth Strategy of Revvity for related context.

Values — Integrity and Quality: favor patient safety via design controls and post-market surveillance; Customer Obsession: prioritize workflow pain points and >95% uptime; Innovation with Purpose: invest in high-sensitivity assays and automation that reduce time-to-result by double digits; Collaboration and Inclusion: cross-functional squads and DEI programs broaden talent and interoperability; Accountability and Execution: stage-gates, milestone PM and customer-success–linked commercial plans; Sustainability and Social Impact: reduce plastics, improve energy efficiency, and support public-health screening programs. These values position Revvity as a regulated, high-trust provider focused on mission-critical assays rather than pure-speed disruption.

Revvity Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Mission and vision shape strategic choices by setting priorities for product investment, partnerships, and market entry; they align teams around measurable clinical and commercial goals. These guiding statements determine resource allocation, M&A targets, and metrics that track impact on patient outcomes and revenue.

Revvity mission, vision & core values — at a glance

Concise framing of purpose, future ambition, and behaviors driving decisions across R&D, commercial, and operations.

• Revvity mission: accelerate actionable biology to improve human health through diagnostics, information, and services.
• Revvity vision: enable data-driven clinical decisions and scalable screening to transform population health outcomes.
• Revvity core values: integrity, scientific rigor, customer focus, and outcome-driven innovation.
• These statements directly inform portfolio mix, partnerships, and operational KPIs.

Portfolio focus

Investment shifts toward prenatal/newborn screening, genomics prep/automation, and cell & gene therapy analytics support the mission to transform human health.

M&A and partnerships

Targeted acquisitions in informatics and assay chemistries plus sequencing/automation partnerships extend the 'data to decisions' capability.

Product development

Voice-of-customer feedback drives specs for turnaround, sensitivity, and cost; AI/analytics aim for 10–30% faster analysis or fewer repeat runs.

Market expansion

Focus on emerging-market maternal and newborn health tenders with training and post-installation metrics like screening coverage and time to diagnosis.

Operational metrics

Targets include installed base uptime > 95%, SLA service response times, and recurring revenue mix > 70% from reagents/consumables.

Patient impact

Millions of patient-impacting tests supported annually through expanded prenatal and newborn screening menus with improved sensitivity and reduced false positives.

The mission and vision prioritize investments, partnerships, and KPIs that drive clinical impact and sustainable revenue — read next: Core Improvements to Company's Mission and Vision. Target Market of Revvity

Revvity Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Four focused improvements can make the Revvity mission and vision more measurable, digitally forward, sustainable, and operationally actionable. These changes align Revvity mission and Revvity vision with market expectations, regulatory trends, and measurable impact targets.

Quantify clinical impact with outcome metrics

Incorporate specific KPIs into the Revvity mission such as reducing sample-to-answer times and improving positive predictive value to track real-world benefit for diagnostics and research customers.

State a clear digital and AI commitment

Elevate Revvity vision to explicitly commit to chemistry-to-cloud analytics and validated AI modules, reflecting the industry shift to software-defined labs and clinical decision support.

Embed measurable sustainability targets

Add scope‑3 reduction goals for consumables and targets for packaging reduction to meet customer procurement mandates and forthcoming EU rules tied to lab operations.

Align mission with partner-access outcomes

Refine Revvity core values and corporate mission statement to include partner-focused targets for access and throughput that drive measurable public-health outcomes.

Improvements

• Sharpen outcome metrics in the mission/vision by quantifying intended impact such as reductions in time-to-result and improvements in positive predictive value across assays.
• Elevate digital and AI commitments explicitly, benchmarking against peers that position data/AI as core to precision medicine and software-defined labs.
• Embed sustainability targets connected to lab operations, including scope 3 for consumables and packaging reduction to meet procurement and EU regulatory requirements.

Refinements

• Add a measurable goal: Enable partners to reduce sample-to-answer times by 30% and increase access to life-saving screening for 50 million newborns annually by 2027.
• State a digital ambition: Provide end-to-end chemistry-to-cloud analytics with validated AI modules that cut analysis time by 25% while maintaining clinical-grade accuracy.

SEO and factual notes: use Revvity mission, Revvity vision, Revvity core values and related terms such as Revvity company purpose, Revvity corporate mission statement and Revvity values and principles throughout communications; cite measurable ambitions like the 30% sample-to-answer reduction and 50 million newborn screenings target to make the Revvity mission vision and values summary concrete. For an expanded company overview see Mission, Vision & Core Values of Revvity

Implementing mission and vision into corporate strategy requires clear mechanisms that translate high-level purpose into measurable programs and daily operations. Effective integration aligns R&D, quality systems, commercial contracts, and leadership reviews to drive clinical impact and operational excellence.

Revvity mission, vision & core values

The Revvity mission focuses on advancing precision medicine and diagnostics; the vision is to enable better health outcomes through scalable laboratory solutions.

• The mission ties R&D investments to clinical utility and measurable patient impact.
• The vision emphasizes scalable, automated workflows to increase access and reduce turnaround times.
• Core values prioritize scientific rigor, customer focus, and regulatory compliance.
• Values guide decisions on partnerships, product lifecycle, and sustainability.

Corporate mission statement 2025

Revvity corporate mission statement centers on enabling labs and clinicians with diagnostic tools that improve outcomes and lower costs.

Values and principles

Revvity values and principles include integrity in data, customer-centric innovation, and compliance with ISO and regulatory standards.

How purpose guides strategy

Revvity company purpose directs portfolio choices toward assays and automation with clear clinical utility and measurable ROI for labs and health systems.

Leadership and communication

Leadership reinforces mission through quarterly reviews, OKRs, and case studies that highlight throughput gains and improved turnaround times.

Implementation

Business initiatives:

• Workflow integration: Turnkey genomics sample prep plus automation reduces manual steps and variability; standardized SOPs and remote support lower error rates and downtime.
• Public health programs: Scale newborn and prenatal screening implementations with training, QC programs, and proficiency testing to sustain sensitivity/specificity targets.
• Quality systems: Enterprise QMS aligned to ISO 13485 and IVDR, with CAPA rigor and supplier audits that maintain reagent consistency across global sites.

Leadership reinforcement:

• Quarterly business reviews tie R&D spend to clinical impact KPIs; leadership highlights case studies of labs achieving higher throughput and lower turnaround times.

Communication:

• Customer education via application notes, validation guides, and outcomes dashboards; internal town halls and OKRs cascade mission/vision to teams.

Formal mechanisms:

• Stage-gate development with clinical utility checkpoints; ethics and compliance training tied to regulated claims; sustainability scorecards for product lines to track material and energy reductions.

Alignment examples:

• Field service metrics linked to customer uptime and first-time fix rates.
• Commercial contracts with performance guarantees around assay throughput and turnaround.

Relevant metrics as of 2025: Revvity reported fiscal-year revenue of approximately $2.8B (2024 pro forma reporting year) with >10% R&D allocation driving diagnostics and laboratory automation; end-user throughput improvements cited in case studies show up to 30% reduction in turnaround time for targeted workflows.

For background on the company history and strategic shifts, see Brief History of Revvity